Alessia Pagani

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Response to Letter to the Editor: "Advancing TMPRSS6-Targeted Therapy for MASLD: Mechanistic and Translational Perspectives".

Response to Letter to the Editor: "Advancing TMPRSS6-Targeted Therapy for MASLD: Mechanistic and Translational Perspectives".

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 14, 2025

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 09, 2025

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

Journal: ESMO open

Published: June 25, 2024

A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.

A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: January 22, 2024

Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Journal: Nature reviews. Endocrinology

Published: December 14, 2023

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Journal: American journal of hematology

Published: November 23, 2023

Cellular and animal models for the investigation of β-thalassemia.

Cellular and animal models for the investigation of β-thalassemia.

Journal: Blood cells, molecules & diseases

Published: April 21, 2023

FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy.

FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy.

Journal: Cell reports. Medicine

Published: February 22, 2023

Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Journal: Nature reviews. Endocrinology

Published: January 19, 2023

Managing the Dual Nature of Iron to Preserve Health.

Managing the Dual Nature of Iron to Preserve Health.

Journal: International journal of molecular sciences

Published: January 15, 2023

FKBP12 inhibits hepcidin expression by modulating BMP receptors interaction and ligand responsiveness in hepatocytes.

FKBP12 inhibits hepcidin expression by modulating BMP receptors interaction and ligand responsiveness in hepatocytes.

Journal: American journal of hematology

Published: November 09, 2022

A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.

A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.

Journal: Kidney international

Published: July 27, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026